M. Dobrovolskaia

Expanding Chemical Space of Nucleic Acid Nanoparticles for Tunable Antiviral-Like Immunomodulatory Responses and Potent Adjuvant Activity.
20260 citationsauthor #21
Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community
20251 citationsauthor #30
Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy
20250 citationsauthor #2
Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges.
20252 citationsauthor #6
Reconfigurable Nucleic Acid Nanoparticles with Therapeutic RNAi Responses to Intracellular Disease Markers
20254 citationsauthor #7
IFN-γ/IL-2 Double-Color FluoroSpot Assay for Monitoring Human Primary T Cell Activation: Validation, Inter-Laboratory Comparison, and Recommendations for Clinical Studies
20254 citationsauthor #8
Transforming Cancer Nanotechnology Data Analysis and User Experience. Part I: Current Challenges and Solutions Provided by caNanoLab
20251 citationsauthor #4
Better the devil you know than the devil you don’t — PEG challenges in nanomedicine
202510 citationsauthor #1
Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition
202510 citationsauthor #11
Changes in Generations of PAMAM Dendrimers and Compositions of Nucleic Acid Nanoparticles Govern Delivery and Immune Recognition
20255 citationsauthor #11
Nanoparticles may influence mast cells gene expression profiles without affecting their degranulation function.
20252 citationsauthor #11
Transforming Cancer Nanotechnology Data Analysis and User Experience. Part II: Providing Future Solutions Using Large Language Models
20250 citationsauthor #4
Structure-function relationship of S protein cleavage in cowpea mosaic virus intratumoral immunotherapy.
20250 citationsauthor #5
Comparative analyses for plant virus-based cancer immunotherapy drug development.
20255 citationsauthor #8
Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus – A cancer immunotherapy candidate
20255 citationsauthor #6
Charting new frontiers in nanoparticle immunotoxicity: A perspective on current, emerging, and future approaches.
20255 citationsauthor #1
Detection of Induction of Mitochondrial Oxidative Stress by Nanoparticles in T Cells Using MitoSOX Red Dye.
20245 citationsauthor #2
Detection of Intracellular Complement Activation by Nanoparticles in Human T Lymphocytes.
20240 citationsauthor #4
Analysis of Nanoparticle Adjuvant Properties.
20240 citationsauthor #3
Immunophenotyping, Part II: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells.
20242 citationsauthor #3
Methods for Analysis of Nanoparticle Immunosuppressive Properties.
20240 citationsauthor #4
In Vitro and In Vivo Methods for Analysis of Nanoparticles' Potential to Induce Delayed-Type Hypersensitivity Reactions.
20242 citationsauthor #3
Immunophenotyping, Part I: Instrument Calibration and Reagent Qualification for Immunophenotyping Analysis of Human Peripheral Blood Mononuclear Cell Cultures.
20241 citationsauthor #3
Detection of Beta-Glucan Contamination in Nanoparticle Formulations.
20240 citationsauthor #2
Cowpea mosaic virus intratumoral immunotherapy maintains stability and efficacy after long‐term storage
202411 citationsauthor #4
Advancements in Nanoparticle Characterization.
20242 citationsauthor #4
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study.
20243 citationsauthor #11
Analysis of Nanoparticles' Potential to Induce Autoimmunity.
20241 citationsauthor #6
Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome.
20248 citationsauthor #14
Detection of Nanoparticle-Mediated Change in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye.
20248 citationsauthor #2
Current Considerations and Practical Solutions for Overcoming Nanoparticle Interference with LAL Assays and Minimizing Endotoxin Contamination.
20241 citationsauthor #2
Immunostimulation of Fibrous Nucleic Acid Nanoparticles Can be Modulated through Aptamer-Based Functional Moieties: Unveiling the Structure–Activity Relationship and Mechanistic Insights
202414 citationsauthor #8
Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum.
20242 citationsauthor #2
Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow-Derived Dendritic Cells After Treatment with Nanoparticles.
20241 citationsauthor #2
Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DCFDA Dye.
20240 citationsauthor #2
Detection of Antigen Presentation by Murine Bone Marrow-Derived Dendritic Cells After Treatment with Nanoparticles.
20241 citationsauthor #2
Understanding the Role of Scavenger Receptor A1 in Nanoparticle Uptake by Murine Macrophages.
20242 citationsauthor #4
Cellular fate of a plant virus immunotherapy candidate
202413 citationsauthor #13
Analysis of Nanoparticles' Effects on Drug-Induced Psoriasis.
20240 citationsauthor #5
Role of physicochemical properties in silica nanoparticle-mediated immunostimulation
20243 citationsauthor #4
Immunological properties of silica nanoparticles: a structure–activity relationship study
202413 citationsauthor #2
Evaluation of non-modified wireframe DNA origami for acute toxicity and biodistribution in mice
20231 citationsauthor #10
Evaluation of Nonmodified Wireframe DNA Origami for Acute Toxicity and Biodistribution in Mice
202333 citationsauthor #10
Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles
20236 citationsauthor #10
Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticles
202312 citationsauthor #5
Special Issue “Nanotechnology to Overcome the World’s Most Critical Health Issues: Liposomes and Beyond—A Themed Issue Dedicated to Professor Yechezkel Barenholz”
20230 citationsauthor #1
Detection of Nanoparticles' Ability to Stimulate Toll-Like Receptors Using HEK-Blue Reporter Cell Lines.
20232 citationsauthor #2
Cancer nanomedicine
2022281 citationsauthor #3
Artificial immune cell, AI-cell, a new tool to predict interferon production by peripheral blood monocytes in response to nucleic acid nanoparticles
202235 citationsauthor #5
Forgotten Relative
20220 citationsauthor #3
Trends and Patterns in Cancer Nanotechnology Research: A Survey of NCI's caNanoLab and Nanotechnology Characterization Laboratory.
202222 citationsauthor #5
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
2022119 citationsauthor #9
Locking and Unlocking Thrombin Function Using Immunoquiescent Nucleic Acid Nanoparticles with Regulated Retention In Vivo.
202214 citationsauthor #16
Expanding Structural Space for Immunomodulatory Nucleic Acid Nanoparticles (Nanps) via Spatial Arrangement of Their Therapeutic Moieties
202226 citationsauthor #13
Innate Immune Stimulation using 3D Wireframe DNA Origami
202262 citationsauthor #3
Lessons learned from immunological characterization of nanomaterials at the Nanotechnology Characterization Laboratory
202231 citationsauthor #1
Anhydrous Nucleic Acid Nanoparticles for Storage and Handling at Broad Range of Temperatures.
202219 citationsauthor #11
Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy.
202224 citationsauthor #6
Immunophenotyping: analytical approaches and role in preclinical development of nanomedicines.
202213 citationsauthor #2
Innate Immunity Modulating Impurities and the Immunotoxicity of Nanobiotechnology-Based Drug Products
20219 citationsauthor #2
Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier
202129 citationsauthor #10
Editorial to "Journey into the Immunological Properties of Engineered Nanomaterials: There and Back Again".
20210 citationsauthor #2
Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm
202114 citationsauthor #9
To PEGylate or not to PEGylate: immunological properties of nanomedicine's most popular component, poly(ethylene) glycol and its alternatives.
2021385 citationsauthor #7
NCL Method ITA-14
20210 citationsauthor #6
An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide
202118 citationsauthor #7
2021: an immunotherapy odyssey and the rise of nucleic acid nanotechnology.
202113 citationsauthor #2
The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.
202130 citationsauthor #4
Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation
202152 citationsauthor #2
The Recognition of and Reactions to Nucleic Acid Nanoparticles by Human Immune Cells
202120 citationsauthor #3
NCL Method ITA-12
20203 citationsauthor #4
NCL Method ITA-17
20200 citationsauthor #5
NCL Method ITA-22
20200 citationsauthor #5
NCL Method ITA-6.1
20200 citationsauthor #5
NCL Method STE-3
20200 citationsauthor #4
NCL Method ITA-9.1
20200 citationsauthor #4
Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activation
20200 citationsauthor #4
NCL Method ITA-25
20200 citationsauthor #5
NCL Method ITA-4
20201 citationsauthor #5
One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.
202092 citationsauthor #7
NCL Method ITA-3
20200 citationsauthor #4
Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
202022 citationsauthor #5
Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.
202030 citationsauthor #5
PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
20208 citationsauthor #4
NCL Method ITA-23
20200 citationsauthor #5
NCL Method ITA-9.2
20200 citationsauthor #4
NCL Method ITA-11
20200 citationsauthor #5
Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology.
202078 citationsauthor #2
NCL Method ITA-2.1
20200 citationsauthor #4
NCL Method ITA-8.1
20200 citationsauthor #4
NCL Method ITA-6.2
20201 citationsauthor #5
NCL Method ITA-18
20200 citationsauthor #5
Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticles
202046 citationsauthor #1
NCL Method ITA-5.1
20201 citationsauthor #3
NCL Method ITA-5.2
20200 citationsauthor #3
NCL Method ITA-8.2
20200 citationsauthor #4
Application of a Scavenger Receptor A1 Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV.
202016 citationsauthor #13
Detection of Beta- Glucan
20200 citationsauthor #2
NCL Method ITA-10
20200 citationsauthor #4
Interference of Metal Oxide Nanoparticles with Coagulation Cascade and Interaction with Blood Components
201911 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT